NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Clinical Oncology


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
AIPL Announces Premier Opthalmic Pathology Consultation Group
2009 NOV 24 ... pathology and immunohistochemistry. Keywords: , Health, Biotechnology, Clinical Trials, Oncology, Optical, Pharmaceutical, Radiology, Information Technol, Data ...
Subject: American International Pathology Laboratories
Price: $3.00
*
Biofield therapies: Helpful or full of hype?
2009 NOV 29 ... scrutiny of current Western scientific methods.In a detailed review of 66 clinical studies looking at biofield therapies in different patient populations with a range of ... Central Nervous System Disease, Clinical Trial Research, Dementia, Mental Disorder, Oncology, Psychiatry, Therapy, Treatment, Springer.This article was prepared by ...
Subject: Springer
Price: $3.00
*
Dermatologists Can Help Separate Fact From Fiction for Sun Exposure, Sunscreen and Vitamin D
2009 NOV 28 ... SKIN academy (Academy), Washington, D.C., dermatologist Elizabeth L. Tanzi, MD, FAAD, clinical faculty in the department of dermatology at Johns Hopkins Hospital Center in Baltimore, ... Blood Pressure, Bone, Dermatology, Hypertension, Insulin Dependent Diabetes Mellitus, Oncology, Pediatrics, Rickets, Skin Cancer, Skin Neoplasms, Type 1 Diabetes, Vitamin D ...
Subject: American Academy of Dermatology
Price: $3.00
*
Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
2009 NOV 28 ... GEST as our most recent partner in the further development of the Endovascular Forum's clinical exchange platform," said Rony Sellam, Chief Strategy and Business Development Officer ... treatment of vascular malformations is fully dependent on embolization techniques. Oncology treatment with drug-eluting and target-specific beads is another fast-growing field of ...
Subject: IC Sciences Corporation
Price: $3.00
*
FDA-approved drugs eliminate, prevent cervical cancer in mice
2009 NOV 29 ... one or two years to complete, could be followed quickly with phase-two or phase-three clinical trials. Early phase trials would not be necessary since the drugs have already been ... all cervical cancers in women test positive for HPV 16," says Lambert, a professor of oncology at the UW-Madison School of Medicine and Public Health.But not everyone who ...
Subject: University of Wisconsin-Madison
Price: $3.00
*
First Patients Complete Treatment at ProCure Proton Therapy Center in Oklahoma City
2009 NOV 28 ... in suburban Detroit, South Florida, Seattle and Somerset, New Jersey.Clinical care at the Oklahoma City Center is being provided by Radiation Medicine Associates ... provided by Radiation Medicine Associates (RMA), one of the state's leading radiation oncology practices. Collectively, RMA's physicians have more than 70 years experience in the ...
Subject: ProCure Treatment Centers, Inc.
Price: $3.00
*
Helicos BioSciences Provides Strategic Update
2009 NOV 24 ... Genetic Analysis System's unique capabilities and have seen an increased interest in clinical applications for which the Helicos system is uniquely suited. Not only do we have a ... hardware." Keywords: , Health, Biotechnology, Genetics, Medical Devices, Oncology, Pharmaceutical, Other Science, Science, Biosci, Chemicals, Chemistry, Finance, ...
Subject: Helicos BioSciences Corporation
Price: $3.00
*
Jared N. Schwartz, M.D., Ph.D., Joins Aperio as Chief Medical Officer
2009 NOV 24 ... Guidelines on HER2, which was published in the January 2007 editions of the Journal of Clinical Oncology and Archives of Pathology and Laboratory Medicine. He is currently a co-chair and one of ...
Subject: Aperio Technologies, Inc.
Price: $3.00
*
News brief: Antitumor activity of nutlin-3 in neuroblastoma with wild-type p53
2009 NOV 29 ... tumor growth and metastasis."These findings support the initiation of clinical trials of selective MDM2 antagonists for treatment of advanced-stage and chemoresistant ... Pediatrics, Anticancer Therapy, Antitumor Activity, Cancer, Hematology, Neuroblastoma, Oncology, Small Molecule Inhibitor, Treatment, Journal of the National Cancer ...
Subject: Journal of the National Cancer Institute
Price: $3.00
*
News brief: Detecting overall survival benefit derived from progression-free survival
2009 NOV 29 ... whether progression-free survival (PFS) or OS is the most appropriate endpoint in clinical trials of metastatic cancer, and to determine if it is reasonable to expect that ... grows and becomes more varied, SPP will get longer. When SPP gets sufficiently long oncology researchers and regulators will have to drop OS as the primary endpoint in clinical ...
Subject: Journal of the National Cancer Institute
Price: $3.00
*
PinnacleHealth First Hospital in the United States to Install Toshiba's Aquilion Premium CT
2009 NOV 28 ... planes, including 3D."The Aquilion Premium was designed to not only improve clinical accuracy, but also to make procedures safer and more efficient while increasing patient ... Technology, Technology, Anatomy, Cancer, Diagnostic Imaging, Diagnostics, Neurology, Oncology, Pediatric, Surgery, Toshiba America Medical Systems.This article was ...
Subject: Toshiba America Medical Systems
Price: $3.00
*
Scientists successfully reprogram blood cells
2009 NOV 28 ... Chemistry, Pediatrics, Biochemical, Cancer Gene Therapy, Central Nervous System Injury, Clinical Trials, Hematology, Hematopoietic, Heparin, Lysosomal Storage Disease, ... Hematopoietic, Heparin, Lysosomal Storage Disease, Mucopolysaccharidoses, Neurology, Oncology, Pathology, Pediatrics, Pre-Trials Research, Stem Cell Research, Treatment, Cincinnati ...
Subject: Cincinnati Children's Hospital Medical Center
Price: $3.00
*
TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post
2009 NOV 24 ... to join TARIS in the position of Chief Medical Officer and Senior Vice President for Clinical Development. Dr. Himes has broad clinical research and operations experience within the ... Himes was responsible for all clinical programs at Coley, including oncology, chronic hepatitis C and autoimmunity, with direct oversight of clinical operations, ...
Subject: TARIS Biomedical Inc.
Price: $3.00
*
VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting
2009 NOV 23 ... all of VisEn's technologies are designed to generate translational data linking pre-clinical research into clinical medicine. Keywords: Angiotensin, Arthritis, ... key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis. The new agent is expected to have a significant impact in cardiovascular ...
Subject: Disease Progression
Price: $3.00
*
Women and cardiovascular health conference to highlight need for gender-specific research
2009 NOV 29 ... women are underrepresented in cardiovascular research in Europe. "In the 62 randomized clinical trials published between 2006 and July 2009, only 33.5% of enrolled participants were ... Hypertension, Malaria, Menopause, Mycobacteria, Mycobacterium Tuberculosis, Obesity, Oncology, Pathology, Rehabilitation Research, Stroke, Therapy, Treatment, Virology, Women's ...
Subject: European Society of Cardiology
Price: $3.00
*
Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds
2009 NOV 23 ... Oncology, Erectile Dysfunction, Impotence, Metabolic Disease, Regulatory Actions, Clinical Trial Research, Epidemiology, Endocrine. This article was prepared by ...
Subject: Kaiser Permanente
Price: $3.00
*
Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology
2009 NOV 23 ... Viral Research, Virology, Xenomics Inc. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009,...
Subject: Xenomics, Inc.
Price: $3.00
*
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
2009 NOV 23 ... peripheral T-cell lymphoma ("PTCL"), were reported at the American Society of Clinical Oncology (ASCO) in May. Supported by these data, the Company expects to advance into a ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*
ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress
2009 NOV 23 ... peripheral T-cell lymphoma ("PTCL"), were reported at the American Society of Clinical Oncology (ASCO) in May. Supported by these data, the Company expects to advance into a ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login